Although we know that the rectifying chloride channel is defective when mutant CFTR is expressed, the relationship between the cystic fibrosis transmembrane conductance regulator (CFTR) and other ion channels in cystic fibrosis (CF) tissues is not known. Cystic fibrosis (CF) is also characterized by increased sodium absorption. This increased sodium absorption adds to the reduced chloride secretion to further diminish normal fluid balance. If sodium hyperabsorption or normal sodium absorption can be inhibited, it may mitigate compromised fluid balance. The cellular basis of the sodium defect in CF is unknown. One possibility is increased absorption through amiloride-sensitive sodium channels. Since nucleotide-gated cation channels are abundantly expressed in lung (bronchi and bronchioles) and gut, (villus cells), two organs involved in cystic fibrosis, this channel may also contribute to hyperabsorption of sodium. If nucleotide-gated cation channels participate in normal sodium absorption or excessive sodium absorption in CF, the dichlorobenzamil inhibitory site on this channel may be a potential site for therapeutic intervention.
The Specific Aims are: 1) To evaluate whether nucleotide-gated cation channels contribute to sodium absorption in tissues involved in CF by determining a) the distribution of nucleotide-gated channels by in situ hybridization in normal seat glands, pancreatic cells and the nasal epithelium b) immunocytochemical localization of the channel in lung, intestine, pancreas and sweat glands and c) the contribution of nucleotide-gated channels to short circuit current of rat tracheal cells. 2) To evaluate the interaction between amiloride-sensitive sodium channels and nucleotide-gated cation channels and CFTR by cotransfection of nucleotide-gated channels with mutated or normal CFTR for study of the properties of channels which may be responsible for hyperabsorption of sodium. Comparisons will be made using whole-cell and single channel recordings. 3) To clone, then characterize the pharmacological and electrophysiological properties of the novel intestinal nucleotide-gated cation channel by expression of cDNA clone(s) in oocytes. To determine if dichlorobenzamil blocks the condition pore of the nucleotide-gated channel.

Project Start
1998-09-30
Project End
2000-08-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Guggino, William B (2004) The cystic fibrosis transmembrane regulator forms macromolecular complexes with PDZ domain scaffold proteins. Proc Am Thorac Soc 1:28-32
Ketchum, Christian J; Rajendrakumar, Garnepudi V; Maloney, Peter C (2004) Characterization of the adenosinetriphosphatase and transport activities of purified cystic fibrosis transmembrane conductance regulator. Biochemistry 43:1045-53
Cheng, Jie; Wang, Hua; Guggino, William B (2004) Modulation of mature cystic fibrosis transmembrane regulator protein by the PDZ domain protein CAL. J Biol Chem 279:1892-8
Swiatecka-Urban, Agnieszka; Duhaime, Marc; Coutermarsh, Bonita et al. (2002) PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 277:40099-105
Cheng, Jie; Moyer, Bryan D; Milewski, Michal et al. (2002) A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression. J Biol Chem 277:3520-9
Ketchum, Christian J; Yue, Hongwen; Alessi, Karen A et al. (2002) Intracellular cysteines of the cystic fibrosis transmembrane conductance regulator (CFTR) modulate channel gating. Cell Physiol Biochem 12:1-8
Norlin, A; Lu, L N; Guggino, S E et al. (2001) Contribution of amiloride-insensitive pathways to alveolar fluid clearance in adult rats. J Appl Physiol 90:1489-96
Ketchum, C J; Schmidt, W K; Rajendrakumar, G V et al. (2001) The yeast a-factor transporter Ste6p, a member of the ABC superfamily, couples ATP hydrolysis to pheromone export. J Biol Chem 276:29007-11
Mickle, J E; Milewski, M I; Macek Jr, M et al. (2000) Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels. Am J Hum Genet 66:1485-95
Moyer, B D; Duhaime, M; Shaw, C et al. (2000) The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane. J Biol Chem 275:27069-74

Showing the most recent 10 out of 39 publications